Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Out-licensing
- View
BIO-011 - INFLAMMATION - Preventing IL-2 Mediated Inflammation in Epithelial Cells
New methods for treating, minimizing and/or preventing inflammatory injury mediated by the activity of interleukin 2 (IL-2) on non-T cells, such as epithelial cells, expressing IL-2 receptors (IL-2R)
Full description
Summary of Invention:
Patent information
A United States provisional patent application has been filed.
Type of business relationship sought
The technology is available for licensing and/or collaborative research and development in partnership with an industry partner.
Licensing contact
Mr. Todd Copeland
Manager
Technology Development/Commercialization
Manager
Technology Development/Commercialization
Company details
LAWSON Business Development
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes.
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes.
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
- Erythropoietin
- Peptides for Prevention of Pathological Calcification
- BIO-012 - CARDIOVASCULAR DISEASE - Novel Pharmacological Approach for the Control of Homocysteine Levels in Patients with End-Stage Renal Disease
- Phytohealth Corporation: PH3 (PHN031, PHN033) - For osteoporosis and diabetic vascular complications
- Uses of Type IV Collagen in regeneration and restoration of renal cell injury (02-28)
Related categories
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us